Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $432494.0.

  • Iradimed's Change in Account Payables rose 4962.29% to $432494.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $49271.0, marking a year-over-year increase of 10407.23%. This contributed to the annual value of -$861618.0 for FY2024, which is 29809.37% down from last year.
  • According to the latest figures from Q3 2025, Iradimed's Change in Account Payables is $432494.0, which was up 4962.29% from -$689064.0 recorded in Q2 2025.
  • Iradimed's Change in Account Payables' 5-year high stood at $1.6 million during Q2 2023, with a 5-year trough of -$1.2 million in Q3 2023.
  • In the last 5 years, Iradimed's Change in Account Payables had a median value of $47490.0 in 2021 and averaged $27073.7.
  • The largest annual percentage gain for Iradimed's Change in Account Payables in the last 5 years was 219023.79% (2022), contrasted with its biggest fall of 610466.97% (2022).
  • Quarter analysis of 5 years shows Iradimed's Change in Account Payables stood at $47490.0 in 2021, then soared by 2190.24% to $1.1 million in 2022, then crashed by 167.68% to -$736084.0 in 2023, then soared by 47.32% to -$387798.0 in 2024, then surged by 211.53% to $432494.0 in 2025.
  • Its Change in Account Payables stands at $432494.0 for Q3 2025, versus -$689064.0 for Q2 2025 and $693639.0 for Q1 2025.